Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.00    1.80 (1.74%)
Bid:
104.40
Ask:
105.00
Spread: 0.60 (0.575%)
Market Cap: £172.14m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Update

29 Dec 2008 07:00

RNS Number : 7991K
Yule Catto & Co PLC
29 December 2008
 



29 December 2008

Yule Catto & Co plc

Update

Yule Catto & Co plc ("the Group") is pleased to announce that it has signed a new three year £30 million revolving loan facility with its principal banks, HSBC and Barclays. This loan replaces its existing revolving bank loan facility maturing in November 2009.

During the course of this re-financing, the Board has been carefully considering the capital structure of the Group.  Whilst much progress has been made on the deleveraging of the balance sheet, with £55 million of gross proceeds received from the sale of three of our five Impact Chemicals businesses, the balance sheet remains a core focus of the Board and it aims to reduce outstanding net debt to below £100 million over the next twelve to twenty four months. The Board believes this is consistent with the Group's objectives, including its financial commitments to the Group's UK pension fund.

Accordingly, and in light of the current financial environment and economic uncertainty, the Board has additionally decided to suspend the payment of dividends until such time as net debt is nearer to its overall target and at which time the business environment and financial market conditions may well have improved. The Board anticipates reverting to the payment of a dividend within two years.

At the time the Group recommences the payment of a dividend, the Board anticipates rebasing it to a level determined by comparison with its peer group and which will allow an appropriate free cash flow to suit the Group's circumstances.

The Board is also pleased to confirm that for 2008 the Group still expects to deliver underlying earnings before tax modestly ahead of last year, despite the current difficult economic conditions particularly in the UK and Continental Europe.

The Board believes it is too early at this time, given the prevailing economic uncertainty, to offer any firm guidance on the outturn for 2009.  The Group's Impact Chemicals and Pharma Chemicals businesses should benefit next year from recent restructuring.  Within our Polymer Chemicals business we anticipate the performance of our Asian and Middle East businesses to be more robust than that of our European businesses, due to local market conditions and a more resilient demand profile from our targeted markets. In addition, the current relative weakness of Sterling against the Dollar, Euro and Malaysian Ringgit, should it continue, will assist the reported Sterling earnings for a number of our businesses.

The Group continues to look at ways to improve efficiency and minimise costs. We currently have a number of initiatives in hand to do this, both within Europe and the rest of the world. 

These are exceptional times, with a high degree of market uncertainty and a very difficult environment for funding.  Having completed £55 million of divestments and put in place a new revolving loanthe Board believes that, together with internal actions to conserve cash and the suspension of the dividend, Yule Catto is now well placed to weather these conditions.

- Ends -

For further information, please contact:

Yule Catto & Co plc
Adrian Whitfield, Chief Executive
David Blackwood, Group Finance Director
 
01279 442791
Hogarth Partnership 
John Olsen
Andrew Jaques
Ian Payne
020 7357 9477
07770 272082

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKQKNNBDDFBB
Date   Source Headline
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update
18th Dec 20147:00 amRNSBoard Changes
18th Nov 20147:00 amRNSAppointment of Group Chief Executive
28th Oct 20147:00 amRNSInterim Management Statement
22nd Oct 20143:00 pmRNSAcquisition
17th Oct 20141:03 pmRNSDirector/PDMR Shareholding
16th Oct 20143:56 pmRNSDirector/PDMR Shareholding
15th Oct 201412:35 pmRNSDirector/PDMR Shareholding
14th Oct 20142:40 pmRNSDirector/PDMR Shareholding
13th Oct 20149:35 amRNSDirector Declaration
11th Aug 20147:00 amRNSInterim Results
11th Jul 20147:00 amRNSTrading update
1st Jul 20147:00 amRNSAdrian Whitfield to step down as CEO
23rd Jun 201412:01 pmRNSHolding(s) in Company
30th May 20149:24 amRNSHolding(s) in Company
15th May 20144:26 pmRNSDirector/PDMR Shareholding
8th May 201411:25 amRNSDirector/PDMR Shareholding
7th May 20144:35 pmRNSDirector/PDMR Shareholding
1st May 20142:47 pmRNSResult of AGM
1st May 20147:00 amRNSInterim Management Statement
14th Apr 20149:23 amRNSHolding(s) in Company
9th Apr 20143:08 pmRNSHolding(s) in Company
9th Apr 201411:26 amRNSHolding(s) in Company
31st Mar 20149:40 amRNSAnnual Financial Report
14th Mar 20144:17 pmRNSHolding(s) in Company
14th Mar 201411:48 amRNSHolding(s) in Company
12th Mar 20142:40 pmRNSDirector/PDMR Shareholding
6th Mar 20144:15 pmRNSDirector/PDMR Shareholding
6th Mar 20144:12 pmRNSDirector/PDMR Shareholding
5th Mar 20147:00 amRNSChanges to Board Committees
4th Mar 20142:14 pmRNSHolding(s) in Company
28th Feb 20147:01 amRNSPreliminary Results
13th Feb 20142:57 pmRNSHolding(s) in Company
16th Jan 20148:53 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSDirectorate Change
6th Dec 20139:34 amRNSHolding(s) in Company
22nd Nov 20134:08 pmRNSHolding(s) in Company
20th Nov 201311:45 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSCapital Markets Day
12th Nov 20135:06 pmRNSHolding(s) in Company
8th Nov 20133:03 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Management Statement
29th Oct 20131:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.